Commonwealth Equity Services LLC Buys 4,000 Shares of Edap Tms S.A. (NASDAQ:EDAP)

Commonwealth Equity Services LLC lifted its position in Edap Tms S.A. (NASDAQ:EDAP) by 5.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 71,260 shares of the medical equipment provider’s stock after buying an additional 4,000 shares during the quarter. Commonwealth Equity Services LLC owned about 0.19% of Edap Tms worth $388,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Roubaix Capital LLC acquired a new stake in Edap Tms in the 1st quarter valued at about $169,000. Miracle Mile Advisors LLC acquired a new stake in shares of Edap Tms in the first quarter valued at approximately $136,000. Finally, Virtu Financial LLC bought a new position in shares of Edap Tms during the 1st quarter worth approximately $82,000. 62.74% of the stock is owned by institutional investors.

Analyst Ratings Changes

EDAP has been the subject of several research analyst reports. StockNews.com downgraded shares of Edap Tms from a “hold” rating to a “sell” rating in a report on Tuesday, September 3rd. HC Wainwright restated a “buy” rating and set a $19.00 price objective on shares of Edap Tms in a research report on Thursday, August 29th.

Edap Tms Price Performance

Shares of NASDAQ EDAP opened at $3.05 on Monday. The stock has a market capitalization of $113.17 million, a PE ratio of -5.65 and a beta of 0.43. Edap Tms S.A. has a fifty-two week low of $2.71 and a fifty-two week high of $8.50. The company has a debt-to-equity ratio of 0.03, a current ratio of 2.45 and a quick ratio of 1.80. The business has a fifty day moving average price of $4.05 and a two-hundred day moving average price of $5.65.

Edap Tms (NASDAQ:EDAP) last issued its earnings results on Wednesday, August 28th. The medical equipment provider reported ($0.18) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.04). The firm had revenue of $16.97 million during the quarter, compared to analyst estimates of $17.16 million. Edap Tms had a negative net margin of 31.68% and a negative return on equity of 36.41%. As a group, equities analysts predict that Edap Tms S.A. will post -0.59 earnings per share for the current fiscal year.

Edap Tms Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.